Telix Pharmaceuticals reports Q1 results

• Telix Pharmaceuticals press release (OTCPK:TLPPF): Q1 Revenue of $114.9M (+18.3% Y/Y).
• Reaffirms guidance for full-year revenue expected to be in the range of $445M to $465M.

More on Telix Pharmaceuticals

• Telix Pharmaceuticals Limited (TLPPF) Q4 2023 Earnings Call Transcript
• QSAM to be acquired by Telix for $33.1M plus $90M CVR